- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03757169
Isometric Hand Grip Training in Obstructive Sleep Apnea (OSA) (OSA)
November 28, 2018 updated by: Rodrigo Pinto Pedrosa, University of Pernambuco
Effect of Isometric Hand Grip Training on Blood Pressure of Hypertensive Patients With Obstructive Sleep Apnea
Obstructive sleep apnea (OSA) is a common clinical condition, involving the development of arterial hypertension.
A Meta analysis study have shown that isometric hand grip training promotes blood pressure reduction.
It is going to be conducted a clinical trail to determine the effects of hand grip training in OSA patients to change the arterial hypertension.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Background: obstructive sleep apnea (OSA) is a common clinical condition, involving the development of arterial hypertension.
Meta analysis study have shown that isometric hand grip strength promotes blood pressure reduction, and its reduction is higher than that observed after aerobic training.
Objective: to analyze the effects of the isometric hand grip on blood pressure changes of patients with uncontrolled arterial hypertension with OSA.
Methods: a randomized controlled trial involving 18 adults with OSA and uncontrolled arterial hypertension of both sexes, randomized between control group (receive general guidelines) and hand grip group.
12 weeks of training with load equivalent to 30% of maximum voluntary capacity was performed.
All participants will be submitted for evaluation of blood pressure (BP) central and brachial, pulse wave velocity, full polysomnography,before and after the study protocol (the change from the baseline at 12 weeks).
Expected results: the authors believe that hand grip training can change (reduce) blood pressure in patient with OSA.
Study Type
Interventional
Enrollment (Anticipated)
18
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
PE
-
Recife, PE, Brazil, 50.100-060
- Recruiting
- Pronto Socorro Cardiológico de Pernambuco - Procape
-
Contact:
- Rodrigo Pedrosa, PhD
- Phone Number: +55 81 31817179
- Email: rppedrosa@terra.com.br
-
Contact:
- Flávio MD Andrade, Ms
- Phone Number: + 55 81 99635 54 17
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
30 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- OSA diagnose based on polysomnography,
- Apnea-Hypopnea Index (AHI) > 5,
- arterial hypertension (systolic arterial pressure > 140 mmHg or diastolic arterial pressure > 90 mmHg)
Exclusion Criteria:
- other heart disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Control group
Verbal informations about the disease, and exercise behavior, and nutrition.
|
The patients will receive verbal orientations about the OSA and the arterial hypertension.
|
|
Active Comparator: Hand grip group
Three supervised sessions por week: 4 series (2 at each arm) of two minutes of isometric hand grip contraction at 30% of maximal voluntary contraction.
Between series there will be two minutes to rest.
|
The patients at the Hand Grip group will perform 12 weeks of hand grip exercises, three times/week for 16 minutes with time to rest.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change at ambulatory blood pressure monitoring
Time Frame: Change from the baseline ambulatory blood pressure monitoring at 12 weeks
|
24h of monitoring blood pressure
|
Change from the baseline ambulatory blood pressure monitoring at 12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change at blood pressure
Time Frame: Change from the baseline brachial blood pressure at 12 weeks
|
Three measurement of brachial blood pressure
|
Change from the baseline brachial blood pressure at 12 weeks
|
|
Chance at Apnea-Hypopnea Index (AHI)
Time Frame: Change from the baseline AHI at 12 weeks
|
Index obtained by the Polysomnography to detect the level of Apnea-Hypopnea Index.
The higher level, the worse the disease.
The value of the AHI between 5 to 15 events/hour means mild disease.
AHI between 16 to 30 events/hour means moderate disease, and more than 30 events/hour means severe disease.
|
Change from the baseline AHI at 12 weeks
|
|
Change at Pulse wave velocity
Time Frame: Change from the baseline pulse wave velocity at 12 weeks
|
To evaluate the pulse wave velocity (femoral, carotid and aortic) to detect the occurrence of arterial disease.
|
Change from the baseline pulse wave velocity at 12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 17, 2017
Primary Completion (Anticipated)
December 1, 2018
Study Completion (Anticipated)
February 1, 2019
Study Registration Dates
First Submitted
November 21, 2018
First Submitted That Met QC Criteria
November 27, 2018
First Posted (Actual)
November 28, 2018
Study Record Updates
Last Update Posted (Actual)
November 30, 2018
Last Update Submitted That Met QC Criteria
November 28, 2018
Last Verified
November 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- isopress03
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
BackBeat Medical IncNot yet recruitingHypertension, Systolic | Hypertension (HTN) | Heart Failure With Preserved Ejection Fraction (HFpEFGeorgia
-
Xuanwu Hospital, BeijingNot yet recruiting
-
Shenzhen Salubris Pharmaceuticals Co., Ltd.Not yet recruiting
-
Instituto de Cardiologia do Rio Grande do SulCompletedHypertension (HTN) | Hypertension ArterialBrazil
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
Franz Rischard, DOAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...Not yet recruitingPulmonary Hypertension | Pulmonary Arterial Hypertension (PAH)United States
-
Abant Izzet Baysal UniversityNot yet recruitingPRIMARY HYPERTENSIONTurkey (Türkiye)
-
SingHealth PolyclinicsNanyang PolytechnicEnrolling by invitationHypertension,EssentialSingapore
-
Hacettepe UniversityBozok UniversityCompletedHypertension | Arterial Hypertension | Systemic HypertensionTurkey (Türkiye)
Clinical Trials on Control
-
Vanderbilt University Medical CenterNational Heart, Lung, and Blood Institute (NHLBI)Enrolling by invitationCritical Illness | Respiratory Failure | Mechanical VentilationUnited States
-
Claudia M. WittCompleted
-
University of California, San FranciscoWithdrawn
-
The George InstituteChanghai Hospital; University of CalgaryRecruitingIschemic Stroke, AcuteCanada, Australia
-
Takeshi MorimotoUniversity of the RyukyusCompletedCoronary Artery Disease | Hypertension | Type 2 Diabetes | DyslipidemiaJapan
-
Queen's University, BelfastPublic Health Agency, Health and Social Care Research and Development; Tiny...Completed
-
Johnson & Johnson Vision Care, Inc.TerminatedRefractive Error CorrectionUnited States
-
Universidad Nacional de Educación a DistanciaMinisterio de Economía y Competitividad, SpainUnknownChronic Pain | FibromyalgiaSpain
-
University of California, Los AngelesThe National Council on Aging; City of Los Angeles Department of Aging; Los Angeles...Completed
-
Vanderbilt University Medical CenterCompleted